KR20170143478A - Ferment collagen for preventing skin aging and improving skin wrinkle and preparing method same - Google Patents
Ferment collagen for preventing skin aging and improving skin wrinkle and preparing method same Download PDFInfo
- Publication number
- KR20170143478A KR20170143478A KR1020170174198A KR20170174198A KR20170143478A KR 20170143478 A KR20170143478 A KR 20170143478A KR 1020170174198 A KR1020170174198 A KR 1020170174198A KR 20170174198 A KR20170174198 A KR 20170174198A KR 20170143478 A KR20170143478 A KR 20170143478A
- Authority
- KR
- South Korea
- Prior art keywords
- collagen
- skin
- fermented
- fermentation
- lactobacillus
- Prior art date
Links
- 102000008186 Collagen Human genes 0.000 title claims abstract description 92
- 108010035532 Collagen Proteins 0.000 title claims abstract description 92
- 229920001436 collagen Polymers 0.000 title claims abstract description 92
- 230000037303 wrinkles Effects 0.000 title claims abstract description 25
- 230000009759 skin aging Effects 0.000 title claims abstract description 20
- 238000000034 method Methods 0.000 title claims description 9
- 241000186605 Lactobacillus paracasei Species 0.000 claims abstract description 29
- 241000218588 Lactobacillus rhamnosus Species 0.000 claims abstract description 20
- 230000000694 effects Effects 0.000 claims abstract description 17
- 238000000855 fermentation Methods 0.000 claims description 51
- 230000004151 fermentation Effects 0.000 claims description 51
- 239000000203 mixture Substances 0.000 claims description 32
- 239000002537 cosmetic Substances 0.000 claims description 22
- 239000006071 cream Substances 0.000 claims description 17
- 239000006210 lotion Substances 0.000 claims description 14
- 235000016709 nutrition Nutrition 0.000 claims description 11
- 231100000245 skin permeability Toxicity 0.000 claims description 11
- 102000029816 Collagenase Human genes 0.000 claims description 9
- 108060005980 Collagenase Proteins 0.000 claims description 9
- 229960002424 collagenase Drugs 0.000 claims description 9
- 238000009792 diffusion process Methods 0.000 claims description 8
- 238000009472 formulation Methods 0.000 claims description 8
- 239000001963 growth medium Substances 0.000 claims description 8
- 238000002474 experimental method Methods 0.000 claims description 7
- 230000005764 inhibitory process Effects 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 239000004480 active ingredient Substances 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 6
- 239000002609 medium Substances 0.000 claims description 4
- 239000000686 essence Substances 0.000 claims description 3
- 239000006260 foam Substances 0.000 claims description 3
- 210000002966 serum Anatomy 0.000 claims description 3
- 239000004902 Softening Agent Substances 0.000 claims description 2
- 239000002453 shampoo Substances 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 abstract description 17
- 244000005700 microbiome Species 0.000 abstract description 13
- 230000001603 reducing effect Effects 0.000 abstract description 3
- 230000035515 penetration Effects 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 40
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 18
- 235000010633 broth Nutrition 0.000 description 10
- 239000004310 lactic acid Substances 0.000 description 9
- 235000014655 lactic acid Nutrition 0.000 description 9
- 241000894006 Bacteria Species 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 8
- -1 3-butyl Chemical group 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 6
- 230000037319 collagen production Effects 0.000 description 6
- 241000186660 Lactobacillus Species 0.000 description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 5
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- 229940039696 lactobacillus Drugs 0.000 description 5
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 210000002615 epidermis Anatomy 0.000 description 4
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 3
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 3
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 238000010306 acid treatment Methods 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 229960001948 caffeine Drugs 0.000 description 3
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 3
- 230000015556 catabolic process Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000011382 collagen catabolic process Effects 0.000 description 3
- 238000012790 confirmation Methods 0.000 description 3
- 238000006731 degradation reaction Methods 0.000 description 3
- 210000004177 elastic tissue Anatomy 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 210000002744 extracellular matrix Anatomy 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 231100000274 skin absorption Toxicity 0.000 description 3
- 230000037384 skin absorption Effects 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- 102000016942 Elastin Human genes 0.000 description 2
- 108010014258 Elastin Proteins 0.000 description 2
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 240000001046 Lactobacillus acidophilus Species 0.000 description 2
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 description 2
- 241000186610 Lactobacillus sp. Species 0.000 description 2
- 239000001888 Peptone Substances 0.000 description 2
- 108010080698 Peptones Proteins 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 230000036570 collagen biosynthesis Effects 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 210000002808 connective tissue Anatomy 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 210000004207 dermis Anatomy 0.000 description 2
- YXVFQADLFFNVDS-UHFFFAOYSA-N diammonium citrate Chemical compound [NH4+].[NH4+].[O-]C(=O)CC(O)(C(=O)O)CC([O-])=O YXVFQADLFFNVDS-UHFFFAOYSA-N 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 229920002549 elastin Polymers 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 238000007429 general method Methods 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 229940039695 lactobacillus acidophilus Drugs 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 239000006072 paste Substances 0.000 description 2
- 235000019319 peptone Nutrition 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
- 229920000053 polysorbate 80 Polymers 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- 230000029663 wound healing Effects 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical class CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 1
- BDKLKNJTMLIAFE-UHFFFAOYSA-N 2-(3-fluorophenyl)-1,3-oxazole-4-carbaldehyde Chemical compound FC1=CC=CC(C=2OC=C(C=O)N=2)=C1 BDKLKNJTMLIAFE-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- 102000016359 Fibronectins Human genes 0.000 description 1
- 108010067306 Fibronectins Proteins 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 1
- 102000005741 Metalloproteases Human genes 0.000 description 1
- 108010006035 Metalloproteases Proteins 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 102000016611 Proteoglycans Human genes 0.000 description 1
- 108010067787 Proteoglycans Proteins 0.000 description 1
- 108010081750 Reticulin Proteins 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical compound OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 229960002903 benzyl benzoate Drugs 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 150000005827 chlorofluoro hydrocarbons Chemical class 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- LMPDLIQFRXLCMO-UHFFFAOYSA-L dipotassium;hydrogen phosphate;phosphoric acid Chemical compound [K+].[K+].OP(O)(O)=O.OP([O-])([O-])=O LMPDLIQFRXLCMO-UHFFFAOYSA-L 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 229940030275 epigallocatechin gallate Drugs 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000003676 hair loss Effects 0.000 description 1
- 208000024963 hair loss Diseases 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical class C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- WRUGWIBCXHJTDG-UHFFFAOYSA-L magnesium sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Mg+2].[O-]S([O-])(=O)=O WRUGWIBCXHJTDG-UHFFFAOYSA-L 0.000 description 1
- 229940061634 magnesium sulfate heptahydrate Drugs 0.000 description 1
- ISPYRSDWRDQNSW-UHFFFAOYSA-L manganese(II) sulfate monohydrate Chemical compound O.[Mn+2].[O-]S([O-])(=O)=O ISPYRSDWRDQNSW-UHFFFAOYSA-L 0.000 description 1
- CDUFCUKTJFSWPL-UHFFFAOYSA-L manganese(II) sulfate tetrahydrate Chemical compound O.O.O.O.[Mn+2].[O-]S([O-])(=O)=O CDUFCUKTJFSWPL-UHFFFAOYSA-L 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- CQDGTJPVBWZJAZ-UHFFFAOYSA-N monoethyl carbonate Chemical compound CCOC(O)=O CQDGTJPVBWZJAZ-UHFFFAOYSA-N 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 239000000700 radioactive tracer Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 229940071089 sarcosinate Drugs 0.000 description 1
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 1
- 239000006152 selective media Substances 0.000 description 1
- 230000036620 skin dryness Effects 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- AYRVGWHSXIMRAB-UHFFFAOYSA-M sodium acetate trihydrate Chemical compound O.O.O.[Na+].CC([O-])=O AYRVGWHSXIMRAB-UHFFFAOYSA-M 0.000 description 1
- 229940087562 sodium acetate trihydrate Drugs 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 230000037373 wrinkle formation Effects 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Tropical Medicine & Parasitology (AREA)
- Cosmetics (AREA)
Abstract
Description
본 발명은 발효 콜라겐 및 그 제조방법에 관한 것으로, 보다 상세하게는 피부노화 방지 및 피부주름 개선용 발효 콜라겐 및 그 제조방법에 관한 것이다.The present invention relates to a fermented collagen and a method for producing the same, and more particularly, to a fermented collagen for preventing skin aging and improving skin wrinkles and a method for producing the same.
화장료의 가장 큰 관심 분야 중 하나는 노화와 관련된 주름, 색소침착, 탄력감소, 피부건조화, 탈모, 모발의 윤기 부족 등이다. 피부는 노화를 통해 다양한 변화를 맞게 된다. 먼저 피부의 구성 성분인 표피, 진피 및 피하조직의 두께가 얇아지고 피부에 탄력을 주는 세포외 기질(Extracellular matrix; ECM) 성분이 변화하게 되는데 그 중 세포외 기질의 70~80%를 차지하는 콜라겐은 나이가 들면서 그 생성이 급격하게 저하되어 주름 생성과 밀접한 관계를 가지게 되고, 피부결합조직을 이루고 있는 콜라겐(collagen), 엘라스틴(elastin), 프로티오글리칸(proteoglycans), 글루코스아미노글리칸(glucosaminoglycan), 라미닌(laminin), 파이브로넥틴(fibronectin) 등은 산화되어 그 기능을 잃어버림으로써 피부가 탄력을 잃고 주름이 과도하게 형성되면서 노인성 피부로 변화되어 간다. 세포외 기질의 결합조직섬유에는 아교섬유(교원섬유, collagen fiber), 세망섬유(reticular fiber), 탄력섬유(탄성섬유, elastic fiber)가 있으며, 이 중 피부결합조직의 70% 정도를 차지하고 있는 콜라겐은 피부의 섬유아세포(fibroblast)에서 대부분 형성된다. 나이가 들면서 피부결합조직 내의 콜라겐 함량이 줄어드는데 이는 콜라겐 합성의 저하와 분해의 촉진에 의한 것이다. 따라서 콜라겐 생합성의 저하와 콜라겐 분해 촉진은 피부주름 형성의 가장 큰 원인이라 할 수 있다. 콜라겐 생합성 과정은 전사 수준(Transcription level)과 해독 후 수준(Post-translation level)에 관여하는 많은 인자(Factor)들에 의해 조절을 받아 변화를 일으키며, 콜라겐 분해는 자외선 등에 의해 콜라겐을 분해하는 콜라게나아제(Collagenase)와 같은 기질금속단백질 분해효소들(Matrix metalloproteases; MMP)의 발현의 촉진으로 콜라겐 분해가 촉진되어 콜라겐 함량이 줄어든다. 아울러 외부 환경에 의해 콜라겐의 변형이 가속화되면서 피부는 주름이 많아지고 깊어지게 된다. 결과적으로 피부노화 현상은 세포의 비균질화, 엘라스틴의 소실, 콜라겐의 파괴, 콜라겐 합성의 감소 및 지연 등에 의해 나타난다. 따라서 피부노화 현상은 피부 표피에서도 일어나지만 이보다는 진피에서 일어나는 현상이라고 볼 수 있다.One of the greatest areas of interest in cosmetics is wrinkling, pigmentation, loss of elasticity, skin dryness, hair loss, and lack of shine in the hair associated with aging. The skin is subject to various changes through aging. First, the thickness of the epidermis, dermis, and subcutaneous tissues, which are components of the skin, is thinned and the extracellular matrix (ECM) component that gives skin elasticity changes. Among them, collagen which accounts for 70 ~ 80% As the age increases, the production thereof is drastically lowered to have a close relationship with wrinkle formation, and collagen, elastin, proteoglycans, glucosaminoglycan, , Laminin, fibronectin, etc. are oxidized and lose their function, causing the skin to lose its elasticity and wrinkles becoming excessively formed and changing into senile skin. There are collagen fibers, collagen fibers, reticular fibers, elastic fibers (elastic fibers, elastic fibers) in the connective tissue of the extracellular matrix. Collagen, which accounts for 70% Are mostly formed in fibroblasts of the skin. As you get older, the collagen content in the connective tissue of the skin decreases, which is due to degradation of collagen synthesis and promotion of degradation. Therefore, degradation of collagen biosynthesis and promotion of collagen degradation are the major causes of wrinkles in the skin. The collagen biosynthesis process is regulated by many factors involved in transcription level and post-translation level, and collagen degradation is triggered by collagenase degrading collagen by ultraviolet rays Promotion of matrix metalloproteases (MMP), such as collagenase, promotes collagen degradation and reduces collagen content. In addition, as the collagen's deformation accelerates due to the external environment, the skin becomes wrinkled and deepened. As a result, skin aging is caused by non-homogenization of cells, loss of elastin, destruction of collagen, reduction and delay of collagen synthesis, and the like. Therefore, the skin aging phenomenon occurs in the epidermis of the skin but can be seen as a phenomenon that occurs in the dermis.
이러한 피부노화에 대한 문제점을 해결하기 위한 다양한 화장료 조성물이 연구되고 있고, 피부의 주름개선 효과는 일부에서 가시적인 성과를 보이고 있다. 예컨대, 피부주름 및 기미, 색소침착 개선을 위해 널리 사용되고 있는 레티노이드류, 그 중에서도 레티놀(retinol)에 대한 피부주름 제거 임상 결과들이 다양하게 보고되고 있고, 레티놀을 함유한 화장료는 일광에 의해 형성된 피부주름살이나 피부처짐, 탄력감소 등을 효과적으로 개선하였다.Various cosmetic compositions have been studied for solving the problem of skin aging, and the wrinkle improvement effect of the skin is visible in some parts. For example, there have been various reports on retinoids widely used for the improvement of skin wrinkles, spots, and pigment deposition, and in particular, clinical results of removing skin wrinkles on retinol. Among them, retinol- And skin deflection and elasticity reduction.
종래 콜라겐의 피부보습 효과 및 상처치유 효과를 이용하기 위하여 화장품, 연고 등과 같은 피부외용제 조성물에 콜라겐을 배합한 제품들이 출시되어 있으나, 이들 제품들은 콜라겐 자체를 피부 표면에 도포하는 것으로서 고분자 물질인 콜라겐의 경피 흡수가 어려워 보습작용 또는 상처치유 효과를 기대할 수 없는 문제가 있다.In order to utilize the skin moisturizing effect and the wound healing effect of the collagen, there have been introduced products containing collagen in the composition for external application for skin such as cosmetics and ointment. However, these products apply collagen itself to the surface of the skin, There is a problem that the transdermal absorption is difficult and a moisturizing action or a wound healing effect can not be expected.
한편, 공개특허공보 제2012-0081454호 및 등록특허공보 제1254403호에서는 다양한 균주를 활용한 발효 콜라겐 제조방법을 개시하고 있으며, 특히 공개특허공보 제2012-0081454호에서는 저분자량의 발효 콜라겐이 제조되어 피부의 진피층에 보다 빠르게 흡수될 수 있는 발효 콜라겐 제조에 관해 언급은 하고 있으나, 발효를 통해 획득되는 콜라겐의 저분자화와 생리활성의 변화, 피부 흡수율을 향상시키는 특정 균주의 활용에 대해서는 명확히 제시하지 않고 있다.On the other hand, Japanese Laid-Open Patent Publication Nos. 2008-0081454 and 1254403 disclose a fermentation collagen production method using various strains. Particularly, in Patent Publication No. 2012-0081454, low molecular weight fermentation collagen is produced Although mention is made on the production of fermentation collagen that can be absorbed more quickly into the dermal layer of the skin, it is not explicitly mentioned about changes in collagen low molecular weight and physiological activity obtained through fermentation and utilization of specific strains for improving skin absorption rate have.
따라서 본 발명은 미생물을 이용한 발효 콜라겐 제조에 있어 우수한 피부노화 방지 및 피부주름 개선 효능을 가지면서 특히 피부투과율이 월등히 향상되도록 하는 특정 미생물을 이용하여 제조되는 발효 콜라겐을 제공하고자 한다.Accordingly, it is an object of the present invention to provide a fermented collagen produced by using a specific microorganism having excellent skin aging resistance and skin wrinkle-reducing effect, particularly in skin fermentation collagen production using microorganisms.
또한 특정 미생물을 이용하여 제조된 발효 콜라겐을 함유한 피부노화 방지 및 피부주름 개선용 화장료 조성물을 제공하고자 한다.The present invention also provides a cosmetic composition for preventing skin aging and improving skin wrinkles containing fermented collagen produced by using a specific microorganism.
또한 특정 미생물을 이용한 최적의 발효 콜라겐 제조방법을 제공하고자 한다.The present invention also provides a method for producing optimal fermentation collagen using specific microorganisms.
상기 과제를 해결하기 위하여 본 발명은, 락토바실러스 파라카제이(Lactobacillus paracasei) 또는 락토바실러스 람노서스(Lactobacillus rhamnosus)로 발효된 피부노화 방지 및 피부주름 개선용 발효 콜라겐을 제공한다.In order to solve the above problems, the present invention provides a fermented collagen for preventing skin aging and improving skin wrinkles fermented with Lactobacillus paracasei or Lactobacillus rhamnosus .
또한 상기 발효 콜라겐은 콜라게나아제 활성 저해율이 20% 이상인 것을 특징으로 하는 발효 콜라겐을 제공한다.Also, the fermentation collagen has a collagenase activity inhibition rate of 20% or more.
또한 상기 발효 콜라겐은 프란츠 확산 세포(Franz diffusion cell)를 이용한 피부 투과도(실험 24시간 경과 기준)가 0.01mg/㎖ 이상인 것을 특징으로 하는 발효 콜라겐을 제공한다.Also, the fermentation collagen is characterized by having a skin permeability (based on 24 hours of the experiment) of at least 0.01 mg / ml using a Franz diffusion cell.
상기 다른 과제 해결을 위하여 본 발명은, 상기 발효 콜라겐을 유효성분으로 함유한 피부노화 방지 및 피부주름 개선용 화장료 조성물을 제공한다.In order to solve the above-mentioned problems, the present invention provides a cosmetic composition for preventing skin aging and improving skin wrinkles containing the fermented collagen as an active ingredient.
또한 상기 화장료 조성물의 제형은 유연화장수, 수렴화장수, 영양화장수, 아이크림, 세럼, 영양크림, 맛사지크림, 클렌징크림, 클렌징로션, 클렌징폼, 클렌징워터, 파우더, 엣센스, 팩, 헤어토닉, 헤어트리트먼트, 샴푸 및 린스로 이루어진 군에서 선택되는 어느 하나인 것을 특징으로 하는 화장료 조성물을 제공한다.The formulations of the cosmetic composition may further comprise at least one selected from the group consisting of softening agents, convergent lotion, nutritional lotion, eye cream, serum, nutritional cream, massage cream, cleansing cream, cleansing lotion, cleansing foam, cleansing water, powder, essence, A cosmetic composition, a cosmetic composition, a cosmetic composition, a shampoo, and a rinse.
상기 또 다른 과제 해결을 위하여 본 발명은, 콜라겐이 혼합된 배지에 락토바실러스 파라카제이(Lactobacillus paracasei) 또는 락토바실러스 람노서스(Lactobacillus rhamnosus)를 첨가 및 발효하여 저분자화된 피부노화 방지 및 피부주름 개선용 발효 콜라겐을 제조하는 방법을 제공한다.In order to solve the above-mentioned problem, the present invention provides a method for preventing and treating low-molecular-weight skin aging and skin wrinkles by adding Lactobacillus paracasei or Lactobacillus rhamnosus to a medium containing collagen, The present invention also provides a method for producing fermented collagen.
또한 상기 락토바실러스 파라카제이(Lactobacillus paracasei) 또는 락토바실러스 람노서스(Lactobacillus rhamnosus)는 107~1010cfu/㎖의 배양액으로 상기 배지 100중량부에 대하여 0.5~5중량부 접종되는 것을 특징으로 하는 방법을 제공한다.The Lactobacillus paracasei or Lactobacillus rhamnosus is inoculated in a culture medium of 10 7 to 10 10 cfu / ml in an amount of 0.5 to 5 parts by weight per 100 parts by weight of the culture medium. ≪ / RTI >
본 발명에 따르면 발효 콜라겐 제조에 이용되는 미생물로서 락토바실러스 파라카제이(Lactobacillus paracasei) 또는 락토바실러스 람노서스(Lactobacillus rhamnosus)를 선택하여 우수한 피부노화 방지 및 피부주름 개선 효능을 가지면서 특히 피부투과 성능이 종래 대비 극적으로 향상되도록 하는 발효 콜라겐을 제공할 수 있다.According to the present invention, Lactobacillus paracasei or Lactobacillus rhamnosus is selected as a microorganism used for fermentation collagen production, and has excellent skin aging prevention and skin wrinkle reducing effect, It is possible to provide a fermentation collagen which is dramatically improved compared to the prior art.
또한 상기 특정 미생물을 이용하여 제조된 발효 콜라겐을 화장료 조성물에 활용함으로써 피부노화 방지 및 피부주름 개선 효능이 우수한 화장료 조성물을 제공할 수 있다.Also, by using the fermentation collagen prepared by using the specific microorganism as the cosmetic composition, it is possible to provide a cosmetic composition having excellent anti-aging effect and skin wrinkle-reducing effect.
또한 발효 콜라겐 제조에 락토바실러스 파라카제이(Lactobacillus paracasei) 또는 락토바실러스 람노서스(Lactobacillus rhamnosus)를 활용함에 있어 피부투과 성능을 극대화할 수 있는 최적의 발효 콜라겐 제조 조건을 제공할 수 있다.In addition, when utilizing Lactobacillus paracasei or Lactobacillus rhamnosus for fermentation collagen production, it is possible to provide optimal conditions for fermentation collagen production that maximizes skin permeation performance.
도 1은 본 발명의 실시예 1에서 SDS-PAGE를 통한 4종의 유산균 발효 배양액 내 콜라겐 발효 패턴을 비교하여 나타낸 사진,
도 2는 본 발명의 실시예 2에서 SDS-PAGE를 통한 유산균 발효 배양액과 산 처리 및 염기 처리 콜라겐의 패턴을 비교하여 나타낸 사진,
도 3은 본 발명의 실시예 3에서 발효 콜라겐의 피부주름 개선 효과를 확인한 결과를 나타낸 그래프,
도 4는 본 발명의 실시예 4에서 콜라겐, 발효 콜라겐, 카페인의 프란츠 확산 세포(Franz diffusion cell)를 이용한 피부 투과도를 비교한 결과를 나타낸 그래프.1 is a photograph showing a comparison of collagen fermentation patterns in four fermentation broths of lactic acid bacteria through SDS-PAGE in Example 1 of the present invention,
FIG. 2 is a photograph showing a comparison of patterns of acid-treated and base-treated collagen with the fermentation broth of lactic acid bacteria through SDS-PAGE in Example 2 of the present invention,
3 is a graph showing the results of confirming the effect of improving the skin wrinkles of fermented collagen in Example 3 of the present invention,
FIG. 4 is a graph showing the skin permeability of collagen, fermented collagen, and caffeine Franz diffusion cells in Example 4 of the present invention.
이하, 실시예를 통하여 본 발명을 상세히 설명하기로 한다. 이에 앞서, 본 명세서 및 청구범위에 사용된 용어나 단어는 통상적이거나 사전적인 의미로 한정해서 해석되어서는 아니 되며, 발명자는 그 자신의 발명을 가장 최선의 방법으로 설명하기 위해 용어의 개념을 적절하게 정의할 수 있다는 원칙에 입각하여, 본 발명의 기술적 사상에 부합하는 의미와 개념으로 해석되어야만 한다. 따라서, 본 명세서에 기재된 실시예의 구성은 본 발명의 가장 바람직한 일실시예에 불과할 뿐이고 본 발명의 기술적 사상을 모두 대변하는 것은 아니므로, 본 출원 시점에 있어서 이들을 대체할 수 있는 다양한 균등물과 변형예들이 있을 수 있음을 이해하여야 한다.
Hereinafter, the present invention will be described in detail with reference to examples. Prior to this, terms and words used in the present specification and claims should not be construed as limited to ordinary or dictionary terms, and the inventor should appropriately interpret the concepts of the terms appropriately The present invention should be construed in accordance with the meaning and concept consistent with the technical idea of the present invention. Accordingly, it is to be understood that the constituent features of the embodiments described herein are merely the most preferred embodiments of the present invention, and are not intended to represent all of the inventive concepts of the present invention, so that various equivalents, And the like.
본 발명자들은 저분자화된 콜라겐을 유효성분으로 함유하는 피부노화 방지 및 피부주름 개선 효과가 있는 화장료 조성물에 대해 예의 연구를 거듭한 결과, 락토바실러스 속 미생물을 이용할 경우 상기 효능 발휘에 효과적이나, 상기 효능을 가지면서도 피부투과도 향상에 있어서는 다양한 락토바실러스 속 미생물에 대해 실험한 결과 특정 미생물로서 락토바실러스 파라카제이(Lactobacillus paracasei) 또는 락토바실러스 람노서스(Lactobacillus rhamnosus)를 이용할 경우에만 최적의 성능 구현이 가능함을 확인하고 본 발명에 이르게 되었다.The inventors of the present invention have conducted intensive studies on a cosmetic composition having anti-aging effect and skin wrinkle effect containing low-molecular-weight collagen as an active ingredient. As a result, it has been found that when lactobacillus microorganisms are used, , It was found that optimal performance can be achieved only when Lactobacillus paracasei or Lactobacillus rhamnosus is used as a specific microorganism in various Lactobacillus microorganisms in order to improve skin permeability And came to the present invention.
따라서 본 발명은 일 양태로서 락토바실러스 파라카제이(Lactobacillus paracasei) 또는 락토바실러스 람노서스(Lactobacillus rhamnosus)로 발효된 피부노화 방지 및 피부주름 개선용 발효 콜라겐을 개시한다.Accordingly, the present invention discloses , as an embodiment, a fermentation collagen for preventing skin aging and improving skin wrinkles fermented with Lactobacillus paracasei or Lactobacillus rhamnosus .
본 발명에 따른 발효 콜라겐은 콜라겐이 혼합된 배지에 락토바실러스 파라카제이(Lactobacillus paracasei) 또는 락토바실러스 람노서스(Lactobacillus rhamnosus)를 첨가 및 발효하여 제조되며, 이를 통해 저분자화된 발효 콜라겐은 피부노화 방지 및 피부주름 개선 효능을 향상시키게 된다.The fermentation collagen according to the present invention is prepared by adding and fermenting Lactobacillus paracasei or Lactobacillus rhamnosus to a medium in which collagen is mixed, whereby the low-molecular-weight fermentation collagen is prevented from aging skin And improve the wrinkle-reducing effect of the skin.
본 발명에서 발효 콜라겐 제조에 사용되는 콜라겐은 중량평균분자량이 50,000~500,000인 것이 사용될 수 있고, 활용 미생물을 고려하여 중량평균분자량이 100,000~300,000인 것이 바람직하게 사용될 수 있다.In the present invention, the collagen to be used for fermentation collagen production may have a weight average molecular weight of 50,000 to 500,000 and a weight average molecular weight of 100,000 to 300,000 in consideration of the microorganism used.
발효 콜라겐 제조를 위한 배양 방법은 예컨대, 락토바실러스 파라카제이(Lactobacillus paracasei) 또는 락토바실러스 람노서스(Lactobacillus rhamnosus)를 배지 100중량부에 107~1010cfu/㎖의 배양액으로 0.5~5중량부 접종시켜 35~39℃에서 1~5일간 배양하여 수행될 수 있고, 바람직하게는 108~109cfu/㎖의 배양액으로 0.5~2중량부 접종시켜 36~38℃에서 2~4일간 배양하여 수행될 수 있다. 이때 배양에 사용되는 배지는 펩톤, 아세트산 나트륨 수화물, 황산 마그네슘 수화물, 황산 망간 수화물, 트윈 80, 시트르산 아암모늄, 인산 이칼륨 및 증류수를 포함하여 구성될 수 있고, 여기에 상기 배지 100중량부에 대하여 1~10중량부, 바람직하게는 2~5중량부의 콜라겐을 혼합하여 사용될 수 있다. 배양 완료 후 배양액을 원심분리하여 유산균과 배양액을 분리함으로써 발효 콜라겐이 제조될 수 있다.A method for culturing fermented collagen is, for example, a method comprising culturing 100 parts by weight of Lactobacillus paracasei or Lactobacillus rhamnosus in 0.5 to 5 parts by weight of a culture medium containing 10 7 to 10 10 cfu / And incubated at 35 to 39 ° C for 1 to 5 days, preferably 0.5 to 2 parts by weight in a culture medium of 10 8 to 10 9 cfu / ml, and cultured at 36 to 38 ° C for 2 to 4 days . At this time, the culture medium used for the culture may include peptone, sodium acetate hydrate, magnesium sulfate hydrate, manganese sulfate hydrate, Tween 80, ammonium citrate, potassium phosphate and distilled water. 1 to 10 parts by weight, preferably 2 to 5 parts by weight of collagen may be mixed and used. After completion of the cultivation, the culture broth is centrifuged to separate the lactic acid bacteria and the culture broth to produce fermented collagen.
이와 같이 제조된 발효 콜라겐은 미생물로서 락토바실러스 파라카제이(Lactobacillus paracasei) 또는 락토바실러스 람노서스(Lactobacillus rhamnosus)를 이용함으로써 타 유산균 균주를 이용할 경우에 비해 콜라겐 저분자화가 매우 우수하여 콜라겐 발효에 가장 적합하며, 본 발명의 일 구현예에 따르면 콜라게나아제 활성 저해율이 20% 이상, 바람직하게는 25% 이상, 더욱 바람직하게는 35% 이상인 발효 콜라겐을 제공할 수 있다.The fermented collagen thus prepared is highly suitable for collagen fermentation by using Lactobacillus paracasei or Lactobacillus rhamnosus as a microorganism and having excellent collagen low molecular weight as compared with other lactic acid bacteria strains According to one embodiment of the present invention, the fermentation collagen having a collagenase activity inhibition rate of 20% or more, preferably 25% or more, more preferably 35% or more can be provided.
또한 본 발명의 일 구현예에 따르면 피부 흡수를 촉진시키는, 구체적으로 프란츠 확산 세포(Franz diffusion cell)를 이용한 피부 투과도(실험 24시간 경과 기준)가 0.01mg/㎖ 이상, 바람직하게는 0.03mg/㎖ 이상, 더욱 바람직하게는 0.05mg/㎖ 이상인 발효 콜라겐을 제공할 수 있다.Also, according to one embodiment of the present invention, skin permeability (based on 24 hours of the experiment) using Franz diffusion cells, which promotes skin absorption, is 0.01 mg / ml or more, preferably 0.03 mg / ml Or more, more preferably 0.05 mg / ml or more.
본 발명의 다른 양태에 따르면 상기 제조되는 발효 콜라겐을 유효성분으로 함유한 피부노화 방지 및 피부주름 개선용 화장료 조성물이 개시된다.According to another aspect of the present invention, a cosmetic composition for preventing skin aging and improving skin wrinkles containing fermented collagen as an active ingredient is disclosed.
상기 화장료 조성물에는 유효성분으로서 상기 발효 콜라겐이 0.1~90중량% 함유될 수 있고, 상기 발효 콜라겐 이외에 화장료 조성물에 통상적으로 이용되는 성분들이 포함될 수 있으며, 예컨대 안정화제, 용해화제, 비타민, 안료 및 향료와 같은 통상적인 보조제, 그리고 담체가 포함될 수 있다.The cosmetic composition may contain 0.1 to 90% by weight of the fermentation collagen as an active ingredient. In addition to the fermented collagen, components commonly used in cosmetic compositions may be included in the cosmetic composition. Examples thereof include stabilizers, dissolving agents, vitamins, , And a carrier.
본 발명에 따른 피부노화 방지 및 피부주름 개선용 화장료 조성물은 당 업계에서 통상적으로 제조되는 어떠한 제형으로도 제조될 수 있으며, 예컨대 용액, 현탁액, 유탁액, 페이스트, 겔, 크림, 로션, 파우더, 비누, 계면활성제-함유 클린징,The cosmetic composition for preventing skin aging and improving skin wrinkles according to the present invention may be prepared in any formulations conventionally produced in the art and may be in the form of solutions, suspensions, emulsions, pastes, gels, creams, lotions, , Surfactant-containing cleansing,
오일, 분말 파운데이션, 유탁액 파운데이션, 왁스 파운데이션, 스프레이 등으로 제형화될 수 있으나, 이에 한정되는 것은 아니다. 보다 상세하게는 유연화장수, 수렴화장수, 영양화장수, 아이크림, 세럼, 영양크림, 맛사지크림, 클렌징크림, 클렌징로션, 클렌징폼, 클렌징워터, 파우더, 엣센스, 팩, 헤어토닉, 헤어트리트먼트, 샴푸, 린스 등의 제형으로 제조될 수 있다.Oils, powder foundations, emulsion foundations, wax foundations, sprays, and the like, but are not limited thereto. More specifically, the present invention relates to a cosmetic composition for cosmetics, such as softening longevity, convergent lotion, nutritional lotion, eye cream, serum, nutritional cream, massage cream, cleansing cream, cleansing lotion, cleansing foam, cleansing water, powder, essence, , Rinse, and the like.
이때, 상기 제형이 페이스트, 크림 또는 겔인 경우에는 담체 성분으로서 동물성유, 식물성유, 왁스, 파라핀, 전분, 트라칸트, 셀룰로오스 유도체, 폴리에틸렌 글리콜, 실리콘, 벤토나이트, 실리카, 탈크, 산화아연 등이 이용될 수 있다.When the formulation is a paste, cream or gel, an animal oil, vegetable oil, wax, paraffin, starch, tracer, cellulose derivative, polyethylene glycol, silicone, bentonite, silica, talc or zinc oxide may be used as the carrier component .
또한 상기 제형이 파우더 또는 스프레이인 경우에는 담체 성분으로서 락토스, 탈크, 실리카, 알루미늄 히드록시드, 칼슘 실리케이트 또는 폴리아미드 파우더가 이용될 수 있고, 특히 스프레이인 경우에는 추가적으로 클로로플루오로히드로카본, 프로판/부탄, 디메틸 에테르와 같은 추진체를 포함할 수 있다.When the formulation is a powder or a spray, lactose, talc, silica, aluminum hydroxide, calcium silicate or polyamide powder may be used as a carrier component. In the case of a spray, in particular, chlorofluorohydrocarbons, propane / Butane, dimethyl ether, and the like.
또한 상기 제형이 용액 또는 유탁액인 경우에는 담체 성분으로서 용매, 용해화제 또는 유탁화제가 이용되고, 예컨대 물, 에탄올, 이소프로판올, 에틸 카보네이트, 에틸 아세테이트, 벤질 알코올, 벤질 벤조에이트, 프로필렌 글리콜, 1,3-부틸글리콜 오일, 글리세롤 지방족 에스테르, 폴리에틸렌 글리콜 또는 소르비탄의 지방산 에스테르가 이용될 수 있다.When the formulation is a solution or an emulsion, a solvent, a solubilizing agent or an emulsifying agent is used as a carrier component, and examples thereof include water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, propylene glycol, 3-butyl glycol oil, glycerol aliphatic ester, polyethylene glycol or fatty acid esters of sorbitan can be used.
또한 상기 제형이 현탁액인 경우에는 담체 성분으로서 물, 에탄올, 프로필렌 글리콜과 같은 액상의 희석제, 에톡실화 이소스테아릴 알코올, 폴리옥시에틸렌 소르비톨 에스테르, 폴리옥시에틸렌 소르비탄 에스테르와 같은 현탁제, 미소결정성 셀룰로오스, 알루미늄 메타히드록시드, 벤토나이트, 아가, 트라칸트 등이 이용될 수 있다.When the formulation is a suspension, the carrier component may be a liquid diluent such as water, ethanol, propylene glycol, a suspension such as ethoxylated isostearyl alcohol, polyoxyethylene sorbitol ester, polyoxyethylene sorbitan ester, Cellulose, aluminum metahydroxide, bentonite, agar, trachant and the like may be used.
또한 상기제형이 계면-활성제 함유 클린징인 경우에는 담체 성분으로서 지방족 알코올 설페이트, 지방족 알코올 에테르 설페이트, 설포숙신산 모노에스테르, 이세티오네이트, 이미다졸리늄 유도체, 메틸타우레이트, 사르코시네이트, 지방산 아미드 에테르 설페이트, 알킬아미도베타인, 지방족 알코올, 지방산 글리세리드, 지방산 디에탄올아미드, 식물성 유, 라놀린 유도체, 에톡실화 글리세롤 지방산 에스테르 등이 이용될 수 있다.In addition, when the formulation is an interface-active agent-containing cleansing, the carrier component may include aliphatic alcohol sulfate, aliphatic alcohol ether sulfate, sulfosuccinic acid monoester, isethionate, imidazolinium derivative, methyltaurate, sarcosinate, fatty acid amide ether Alkylamido betaine, aliphatic alcohol, fatty acid glyceride, fatty acid diethanolamide, vegetable oil, lanolin derivative, ethoxylated glycerol fatty acid ester, and the like can be used.
이하, 실시예를 들어 본 발명을 상세히 설명하기로 한다.
Hereinafter, the present invention will be described in detail with reference to examples.
실시예Example 1: 콜라겐 발효 및 발효 산물 확인 1: Confirmation of collagen fermentation and fermentation products
고분자 콜라겐(Mw 100,000~300,000)을 락토바실러스 속 유산균을 이용, 발효 조건을 달리하여 발효 후 콜라겐의 분자량 확인을 통해 콜라겐 발효 효율이 가장 우수한 락토바실러스 속을 찾기 위해 최소 배지 배양 실험을 실시하였다.After the fermentation of collagen (Mw 100,000 ~ 300,000) using Lactobacillus sp. Lactic acid bacteria, fermentation conditions of collagen were examined. The minimum culture conditions were investigated to find Lactobacillus sp.
유산균의 균종으로 락토바실러스 아시도필러스(Lactobacillus acidophilus), 락토바실러스 플란타넘(Lactobacillus plantanum), 락토바실러스 람노서스(Lactobacillus rhamnosus) 및 락토바실러스 파라카제이(Lactobacillus paracasei)를 사용하였으며, 모두 한국세포주 은행에서 구입하여 사용되었다. Lactobacillus acidophilus , Lactobacillus plantanum , Lactobacillus rhamnosus and Lactobacillus paracasei were used as the strains of the lactic acid bacteria, It was purchased from a bank and used.
상기 총 4종의 유산균 균주를 선택 배지에 순수 배양하여 각 균주의 균수가 108~109cfu/㎖ 정도 되는 배양액을 1중량% 함량으로 접종하고, 37℃의 인큐베이터에서 72시간 동안 배양하여 진행하였다. 배양에 사용된 배지로는 펩톤 5g, 아세트산 나트륨 3 수화물 2.5g, 황산 마그네슘 7 수화물 0.5㎖, 황산 망간 4 수화물 0.5㎖, 트윈 80 5㎖, 시트르산 이암모늄(diammonium citrate) 1g, 인산 이칼륨(dipotassium phosphate) 1g 및 증류수 480㎖로 구성된 최소 배지에 15g의 콜라겐이 혼합된 배지를 사용하였다.All four lactic acid bacterial strains were inoculated in a selective medium and inoculated at a concentration of 1 8 wt% in a culture medium in which the number of bacterial strains was about 10 8 to 10 9 cfu / ml, cultured in an incubator at 37 ° C for 72 hours Respectively. 5 g of peptone, 2.5 g of sodium acetate trihydrate, 0.5 ml of magnesium sulfate heptahydrate, 0.5 ml of manganese sulfate tetrahydrate, 5 ml of tween 80, 1 g of diammonium citrate, 1 g of dipotassium phosphate phosphate and 480 ml of distilled water was used as a culture medium in which 15 g of collagen was mixed.
배양이 완료된 후 배양액을 4,000rpm으로 10분 동안 원심분리하여 유산균과 배양액을 분리한 후 분리된 배양액을 SDS-PAGE를 활용하여 콜라겐의 저분자화를 확인하였으며, 도 1에 그 결과를 비교하여 나타내었다. 도 1에서 레인 1 내지 6은 각각 발효 전, 락토바실러스 아시도필러스(Lactobacillus acidophilus) 발효, 락토바실러스 플란타넘(Lactobacillus plantanum) 발효, 락토바실러스 람노서스(Lactobacillus rhamnosus) 발효, 락토바실러스 파라카제이(Lactobacillus paracasei) 발효 및 단백질 크기 마커(protein size marker)를 나타낸다.After the cultivation was completed, the culture broth was centrifuged at 4,000 rpm for 10 minutes to separate the lactic acid bacteria and the culture broth. The separated culture broth was confirmed to have low molecular weight collagen using SDS-PAGE, .
도 1을 참조하면, 총 4종의 유산균 균주 중 락토바실러스 람노서스(Lactobacillus rhamnosus)와 락토바실러스 파라카제이(Lactobacillus paracasei)로 발효했을 때 저분자화가 많이 진행되고, 락토바실러스 파라카제이(Lactobacillus paracasei)로 발효했을 때 저분자화가 가장 많이 진행된 것을 확인할 수 있었으며 콜라겐 발효에 가장 적합한 것으로 확인되었다.
1, when fermentation was performed with Lactobacillus rhamnosus and Lactobacillus paracasei among four lactic acid bacteria strains, a lot of low-molecular-weight fermentation proceeded, and Lactobacillus paracasei ( Lactobacillus paracasei ) And it was confirmed that most of the low - molecular - weight fermentation was most suitable for collagen fermentation.
실시예Example 2: 발효와 산, 염기 처리를 통한 콜라겐 2: Collagen through fermentation, acid and base treatment 저분자화의Low-molecular-weight 비교 compare
실시예 1에서 얻은 락토바실러스 파라카제이(Lactobacillus paracasei) 및 락토바실러스 람노서스(Lactobacillus rhamnosus)로 발효한 발효 배양액과 산 처리(1M HCl로 콜라겐에 1시간 처리한 후 pH 6.5로 중화) 및 염기 처리(1M NaOH로 콜라겐에 1시간 처리한 후 pH 6.5로 중화)를 통해 획득한 콜라겐의 비교를 위해 4종의 샘플에 대해 SDS-PAGE를 진행하여 확인하였으며, 도 2에 그 결과를 비교하여 나타내었다. 도 2에서 레인 1 내지 5는 각각 산 처리, 염기 처리, 단백질 크기 마커(protein size marker), 락토바실러스 파라카제이(Lactobacillus paracasei) 발효 및 락토바실러스 람노서스(Lactobacillus rhamnosus) 발효를 나타낸다.The fermentation broth fermented with Lactobacillus paracasei and Lactobacillus rhamnosus obtained in Example 1 and acid treatment (neutralized with 1M HCl for 1 hour and collagen at pH 6.5) and base treatment (1 mM NaOH for 1 hour and then neutralized to pH 6.5). The results were compared in FIG. 2 by comparing the results of the SDS-PAGE of the four samples . In FIG. 2,
도 2를 참조하면, SDS-PAGE를 통해 확인한 결과 산 처리, 염기 처리 및 락토바실러스 람노서스(Lactobacillus rhamnosus) 발효 콜라겐 역시 콜라겐의 저분자화에 효과가 있으나, 락토바실러스 파라카제이(Lactobacillus paracasei) 발효 배양액 내 콜라겐이 가장 균질하게 저분자화되어 있음을 확인하였다.
2, it was confirmed through SDS-PAGE that acid treatment, base treatment, and Lactobacillus rhamnosus fermentation collagen were also effective for low molecular weight collagen. However, the fermentation broth of Lactobacillus paracasei fermentation broth It was confirmed that the collagen of the present invention was most homogeneously and low molecular weight.
실시예Example 3: 발효 콜라겐의 피부주름 개선 효과 확인 3: Confirmation of improvement of skin wrinkles of fermented collagen
실시예 1에서 얻은 발효 콜라겐의 피부주름 개선 효과를 확인을 확인하기 위해 하기와 같이 생체외(In vitro) 콜라게나아제(collagenase) 활성 저해 시험을 진행하였고, 그 결과를 도 3에 나타내었다.
In order to confirm the effect of improving the skin wrinkle of the fermentation collagen obtained in Example 1, the in vitro collagenase activity inhibition test was carried out as described below, and the results are shown in FIG.
[콜라게나아제(collagenase) 활성 저해 시험 방법][Collagenase activity inhibition test method]
1. 콜라겐을 인산 완충액에 녹여 준비한다(100, 50, 25ppm). 이때 양성 대조군으로 EGCG(Epigallocatechin gallate)을 같은 농도로 준비한다.1. Prepare collagen by dissolving in phosphate buffer (100, 50, 25ppm). At this time, EGCG (Epigallocatechin gallate) is prepared at the same concentration as a positive control group.
2. 48well에서 용매(DMSO)를 이용하여 적당한 농도 범위로 희석하여 테스트 샘플을 300㎕/48well씩 준비한다.2. Prepare a test sample at 300 μl / 48 well by diluting to a suitable concentration range using a solvent (DMSO) at 48 wells.
3. 하기 표 1을 참조하여 15㎖ 글래스 튜브를 준비하고, 하기 표 2와 같은 순서로 용액을 분주한다.3. Referring to the following Table 1, a 15 ml glass tube is prepared, and the solution is dispensed in the order shown in Table 2 below.
4. 25mM 시트르산을 400㎕/tube 첨가하여 반응을 종료시킨다.4. Add 25 mM citric acid (400 μl / tube) to terminate the reaction.
5. 에틸아세테이트를 1.5㎖/tube 첨가하고, 볼텍싱(vortexing)한 후 10분간 방치한다.5. Add 1.5 ml / tube of ethyl acetate, vortex and leave for 10 minutes.
6. 상등액을 취하여 황산나트륨 150mg/ep-tube에 옮기고, 볼텍싱 후 원심분리(10,000rpm, 3분)한다.6. Take supernatant, transfer to sodium sulfate 150 mg / ep-tube, vortex and centrifuge at 10,000 rpm for 3 minutes.
7. 상등액 300㎕/ep-tube를 취하여 석영 96well 플레이트에 옮긴 후 320nm에서 흡광도를 측정한다.
7. Take supernatant 300 μl / ep-tube and transfer to quartz 96-well plate. Measure absorbance at 320 nm.
도 3을 참조하면, 생체외 콜라게나아제 활성 저해 시험을 실시한 결과 발효 전 콜라겐이나 산 처리 및 염기 처리 콜라겐에 비해 락토바실러스 파라카제이(Lactobacillus paracasei) 발효 시 콜라게나아제 활성의 저해율이 우수한 것을 확인할 수 있다.
3, the in vitro collagenase activity inhibition test showed that the inhibition rate of collagenase activity was excellent when fermentation of Lactobacillus paracasei was performed compared to pre-fermentation collagen and acid-treated and base-treated collagen. .
실시예Example 4: 발효 콜라겐의 피부 투과도 향상 확인 4: Confirmation of improved skin permeability of fermented collagen
발효 콜라겐의 피부 투과도 향상을 확인하기 위해 인체의 표피 층(Epidermis)을 대상으로 하여 하기와 같이 프란츠 확산 세포(Franz diffusion cell)를 이용한 피부 투과도 비교 실험을 실시하였고, 그 결과를 도 4에 나타내었다.
In order to confirm the enhancement of the skin permeability of the fermentation collagen, a skin permeability comparative experiment using a Franz diffusion cell was performed on the epidermis of the human body as described below, and the results are shown in FIG. 4 .
[피부 투과도 실험 방법][Experimental method of skin permeability]
1. 프란츠 확산 세포(Franz diffusion cell)의 수용 챔버(receptor chamber)에 인산 완충용액을 6.5㎖ 채우고, 각질층이 위로 향하도록 도너 챔버(donor chamber)와 수용 챔버(receptor chamber) 사이에 인체 사체의 피부(cadaver)를 고정시킨다. 사용한 커대버(cadaver)로는 한스바이오메드(주)의 epidermis skin을 활용하였다.1. Fill the receptor chamber of the Franz diffusion cell with 6.5 ml of phosphate buffer solution and place the horny layer face up on the skin of the human body between the donor chamber and the receptor chamber. (cadaver). The epidermis skin of Hans Biomed was used as the cadaver used.
2. 도너 챔버(Donor chamber)에는 비교군으로 발효 콜라겐과 일반 콜라겐의 농도가 1mg/㎖인 수용액, 양성 대조군으로 카페인 1mg/㎖ 농도의 수용액을 준비하여 담지한다.2. In the donor chamber, an aqueous solution having a concentration of 1 mg / ml of fermentation collagen and normal collagen is prepared as a comparative group, and an aqueous solution having a concentration of 1 mg / ml of caffeine is prepared as a positive control.
3. 실험이 진행되는 동안 35±1℃로 온도를 유지하고 계속해서 자석교반 한다.3. Keep the temperature at 35 ± 1 ° C during the experiment and continue stirring the magnet.
4. 0.5, 1, 3, 5, 8, 12 및 24시간 후 수용 챔버(receptor chamber) 내 각각의 시료를 샘플링 포트(sampling port)에서 채취한다.4. At 0.5, 1, 3, 5, 8, 12, and 24 hours, each sample in the receptor chamber is sampled at a sampling port.
5. 시간 별 샘플 내 콜라겐, 카페인의 함량은 HPLC 분석을 통해 확인하여 피부 투과량, 피부 투과도를 구하고, 비교군과 대조군을 비교한다.
5. The amount of collagen and caffeine in the sample by time is checked by HPLC analysis, and the skin permeation amount and skin permeability are determined, and the comparison group and the control group are compared.
도 4를 참조하면, 프란츠 확산 세포(Franz diffusion cell)를 이용한 피부 투과도 비교 실험을 실시한 결과 발효 전 콜라겐은 큰 분자량으로 피부 침투가 거의 이루어지지 않으나 락토바실러스 파라카제이(Lactobacillus paracasei) 발효 콜라겐은 시간에 비례하여 프란츠 확산 세포(Franz diffusion cell)의 수용 챔버(receptor chamber)와 도너 챔버(donor chamber) 사이의 커대버(cadaver)를 통과하여 수용 챔버(receptor chamber)에서 발견되었다. 본 실시예를 통해 락토바실러스 파라카제이(Lactobacillus paracasei)를 이용하여 발효된 콜라겐은 콜라겐의 피부 흡수를 현저히 촉진시키는 것을 확인하였다.
4, the skin permeability comparison experiment using Franz diffusion cell showed that collagen before fermentation hardly penetrated into skin with a large molecular weight, but Lactobacillus paracasei fermentation collagen had a tendency to increase in time Was found in the receptor chamber through the cadaver between the receptor chamber and the donor chamber of the Franz diffusion cell in proportion to the size of the donor chamber. Through this example, it was confirmed that collagen fermented using Lactobacillus paracasei significantly promotes skin absorption of collagen.
이하에서는 본 발명에 따른 발효 콜라겐을 유효성분으로 함유한 피부노화 방지 및 피부주름 개선용 화장료 조성물의 적용 제조예를 설명하나, 이에 한정되는 것은 아니다.
Hereinafter, a production example of applying a cosmetic composition for preventing skin aging and improving skin wrinkles containing fermented collagen according to the present invention as an active ingredient will be described, but the present invention is not limited thereto.
제조예Manufacturing example 1: 유연화장수 제조 1: Production of softened longevity
실시예 1에 따라 제조된 락토바실러스 파라카제이(Lactobacillus paracasei) 발효 콜라겐을 포함하며, 하기 표 3의 조성으로 이루어진 유연화장수를 일반적인 화장수 제조방법에 따라 제조하였다. Lactobacillus paracasei fermented collagen prepared according to Example 1 and having the composition shown in the following Table 3 was prepared according to the general method of producing lotion.
제조예Manufacturing example 2: 영양크림 제조 2: Nutritional cream manufacture
실시예 1에 따라 제조된 락토바실러스 파라카제이(Lactobacillus paracasei) 발효 콜라겐을 포함하며, 하기 표 4의 조성으로 이루어진 영양크림을 일반적인 영양크림 제조방법에 따라 제조하였다.A nutritional cream containing Lactobacillus paracasei fermented collagen prepared according to Example 1 and having the composition shown in Table 4 below was prepared according to the general nutrition cream preparation method.
제조예Manufacturing example 3: 영양화장수 제조 3: Nutritional lotion manufacturing
실시예 1에 따라 제조된 락토바실러스 파라카제이(Lactobacillus paracasei) 발효 콜라겐을 포함하며, 하기 표 5의 조성으로 이루어진 영양화장수를 일반적인 화장수 제조방법에 따라 제조하였다.Nutritional lotion comprising Lactobacillus paracasei fermented collagen prepared according to Example 1 and having the composition shown in the following Table 5 was prepared according to the general method of producing lotion.
제조예Manufacturing example 4: 4: 엣센스Essence 제조 Produce
실시예 1에 따라 제조된 락토바실러스 파라카제이(Lactobacillus paracasei) 발효 콜라겐을 포함하며, 하기 표 6의 조성으로 이루어진 엣센스를 일반적인 엣센스 제조방법에 따라 제조하였다. Lactobacillus paracasei fermented collagen prepared according to Example 1 and comprising the composition of the following Table 6 was prepared according to the general essence production method.
이상에서 설명한 본 발명의 바람직한 실시예들은 기술적 과제를 해결하기 위해 개시된 것으로, 본 발명이 속하는 기술분야에서 통상의 지식을 가진 자라면 본 발명의 사상 및 범위 안에서 다양한 수정, 변경, 부가 등이 가능할 것이며, 이러한 수정 변경 등은 이하의 특허청구범위에 속하는 것으로 보아야 할 것이다.While the preferred embodiments of the present invention have been disclosed for illustrative purposes, those skilled in the art will appreciate that various modifications, additions and substitutions are possible, Such modifications and changes are to be considered as falling within the scope of the following claims.
Claims (7)
상기 발효 콜라겐은 콜라게나아제 활성 저해율이 20% 이상인 것을 특징으로 하는 발효 콜라겐.The method according to claim 1,
Wherein the fermentation collagen has a collagenase activity inhibition rate of 20% or more.
상기 발효 콜라겐은 프란츠 확산 세포(Franz diffusion cell)를 이용한 피부 투과도(실험 24시간 경과 기준)가 0.01mg/㎖ 이상인 것을 특징으로 하는 발효 콜라겐.3. The method of claim 2,
Wherein the fermentation collagen has a skin permeability (based on 24 hours as an experiment) of at least 0.01 mg / ml using a Franz diffusion cell.
상기 화장료 조성물의 제형은 유연화장수, 수렴화장수, 영양화장수, 아이크림, 세럼, 영양크림, 맛사지크림, 클렌징크림, 클렌징로션, 클렌징폼, 클렌징워터, 파우더, 엣센스, 팩, 헤어토닉, 헤어트리트먼트, 샴푸 및 린스로 이루어진 군에서 선택되는 어느 하나인 것을 특징으로 하는 화장료 조성물.5. The method of claim 4,
The formulation of the cosmetic composition may be selected from the group consisting of softening agents, convergent lotion, nutritional lotion, eye cream, serum, nutritional cream, massage cream, cleansing cream, cleansing lotion, cleansing foam, cleansing water, powder, essence, , Shampoo, and rinse. ≪ RTI ID = 0.0 > 11. < / RTI >
상기 락토바실러스 파라카제이(Lactobacillus paracasei) 또는 락토바실러스 람노서스(Lactobacillus rhamnosus)는 107~1010cfu/㎖의 배양액으로 상기 배지 100중량부에 대하여 0.5~5중량부 접종되는 것을 특징으로 하는 방법.The method according to claim 6,
Wherein said Lactobacillus paracasei or Lactobacillus rhamnosus is inoculated with 0.5 to 5 parts by weight per 100 parts by weight of said medium in a culture medium containing 10 7 to 10 10 cfu / .
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020170174198A KR101895174B1 (en) | 2017-12-18 | 2017-12-18 | Ferment collagen for preventing skin aging and improving skin wrinkle and preparing method same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020170174198A KR101895174B1 (en) | 2017-12-18 | 2017-12-18 | Ferment collagen for preventing skin aging and improving skin wrinkle and preparing method same |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020160016522A Division KR20170095461A (en) | 2016-02-12 | 2016-02-12 | Ferment collagen for preventing skin aging and improving skin wrinkle and preparing method same |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20170143478A true KR20170143478A (en) | 2017-12-29 |
KR101895174B1 KR101895174B1 (en) | 2018-09-04 |
Family
ID=60939355
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020170174198A KR101895174B1 (en) | 2017-12-18 | 2017-12-18 | Ferment collagen for preventing skin aging and improving skin wrinkle and preparing method same |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101895174B1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20200087015A (en) * | 2019-01-10 | 2020-07-20 | 에이앤펩주식회사 | Fermented composition of ice plant and collagen for anti-aging and anti-wrinkle, method for preparing the same and cosmetic composition comprising the same |
KR102491324B1 (en) * | 2022-07-05 | 2023-01-26 | 일동바이오사이언스(주) | Method for lowering molecular-weight of collagen using fermentation of Lacticaseibacillus rhamnosus IDCC 3201 and complex comprising collagen and postbiotics |
WO2023099351A1 (en) * | 2021-11-30 | 2023-06-08 | Dupont Nutrition Biosciences Aps | Lactobacilli for skin aging |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20120079964A (en) * | 2011-01-06 | 2012-07-16 | 샘표식품 주식회사 | Method for preparing fermented collagen peptide |
KR20120081454A (en) * | 2011-01-11 | 2012-07-19 | 박성우 | Manufacturing method of fermented collagen |
-
2017
- 2017-12-18 KR KR1020170174198A patent/KR101895174B1/en active IP Right Grant
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20120079964A (en) * | 2011-01-06 | 2012-07-16 | 샘표식품 주식회사 | Method for preparing fermented collagen peptide |
KR20120081454A (en) * | 2011-01-11 | 2012-07-19 | 박성우 | Manufacturing method of fermented collagen |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20200087015A (en) * | 2019-01-10 | 2020-07-20 | 에이앤펩주식회사 | Fermented composition of ice plant and collagen for anti-aging and anti-wrinkle, method for preparing the same and cosmetic composition comprising the same |
WO2023099351A1 (en) * | 2021-11-30 | 2023-06-08 | Dupont Nutrition Biosciences Aps | Lactobacilli for skin aging |
KR102491324B1 (en) * | 2022-07-05 | 2023-01-26 | 일동바이오사이언스(주) | Method for lowering molecular-weight of collagen using fermentation of Lacticaseibacillus rhamnosus IDCC 3201 and complex comprising collagen and postbiotics |
Also Published As
Publication number | Publication date |
---|---|
KR101895174B1 (en) | 2018-09-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111225659B (en) | Anti-aging composition comprising extracellular vesicles of lactic acid bacteria origin | |
JP2011529486A (en) | Cosmetic composition for preventing skin aging containing mung bean fermentation-enzyme extract | |
KR101895174B1 (en) | Ferment collagen for preventing skin aging and improving skin wrinkle and preparing method same | |
KR100757175B1 (en) | Skin compositions for external application for improving wrinkle and enhancing skin elasticity comprising kaempferol from green tea | |
KR20200049122A (en) | Anti-aging composition comprising functional peptides and fermented products | |
KR20170095461A (en) | Ferment collagen for preventing skin aging and improving skin wrinkle and preparing method same | |
KR101855207B1 (en) | Cosmetic composition containing fermentative extract of terminalia ferdinandiana with increased amount of vitamin c fermented by aureobasidium pullulans | |
KR101040508B1 (en) | Cosmetic Composition for Anti-aging and moisturizing of the Skin Comprising Phaseolus radiatus seed extracts by fermentation and enzyme treatment | |
KR20170055172A (en) | Cosmetic Composition Comprising Extracts of Centipeda minima | |
KR101749657B1 (en) | Cosmetic Composition Comprising Fermented product of Dendropanax morbifera Sap as Active Ingredient | |
KR101883307B1 (en) | Cosmetic composition for improving skin wrinkle comprising extracts of hibiscus hamabo leaf as active ingredient | |
KR20170128726A (en) | Cosmetics composition for anti-aging comprising agar-derived neoagarotetraose | |
KR20190062173A (en) | Cosmetic composition for anti-wrinkle and anti-aging comprising protease-activated recepter2(par2) agonist | |
JP2009242310A (en) | Involucrin production promoter, transglutaminase-1 production promoter, e-cadherin production promoter and skin care preparation for external use for making skin pore inconspicuous | |
WO2018108973A1 (en) | Oligopeptide fraction obtained from a biomass of bacterium or bacteria belonging to the genus vitreoscilla sp, as a cosmetic active ingredient | |
US11376212B2 (en) | Skin whitening composition comprising cultured product of Bacillus hwajinpoensis or extract thereof | |
KR20210144725A (en) | Anti-aging, antioxidant, anti-inflammatory and whitening agents, and cosmetics | |
KR20220141191A (en) | Composition for Skin Whitening, Moisturizing, Strengthening Skin Barrier, Skin Cell Regeneration, and Anti-Wrinkle Property Comprising Fermented Extract of Broussonetia kazinoki as Active Ingredient | |
KR102021322B1 (en) | A cosmetic composition containing fermented broussonetia kazinoki siebold and setaria italica and the method thereof | |
KR20210067567A (en) | Cosmetic composition for improving skin wrinkle comprising extract of plumeria alba flower and lilium concolor var | |
EP3517599A1 (en) | Composition for improving skin condition including fermented pearl product | |
KR20140072419A (en) | Anti-Wrinkle Composition | |
KR20150031365A (en) | Cosmetic Composition for Improving Skin Wrinkle Comprising the Fulvic acid | |
KR102541770B1 (en) | Cosmetic Composition for Improving Skin Elasticity Comprising Extract of Fermented Sambucus Nigra Flower As Active Ingredient | |
KR102131774B1 (en) | Cosmetic Composition Containing Extract of Trichaptum Abietinum for Improving Skin Wrinkle |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A107 | Divisional application of patent | ||
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |